Actinium Pharmaceuticals
ATNM
42 hedge funds and large institutions have $8.23M invested in Actinium Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 3 closing their positions.
953% more call options, than puts
Call options by funds: $158K | Put options by funds: $15K
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
17% more funds holding
Funds holding: 36 → 42 (+6)
0.01% more ownership
Funds ownership: 0.3% → 0.31% (+0.01%)
48% less capital invested
Capital invested by funds: $15.9M → $8.23M (-$7.65M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$966K |
| 2 |
Bank of New York Mellon
New York
|
+$381K |
| 3 |
Renaissance Technologies
New York
|
+$376K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$357K |
| 5 |
State Street
Boston,
Massachusetts
|
+$266K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Patten & Patten
Chattanooga,
Tennessee
|
-$359K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$301K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$224K |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$141K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$76K |
ATNM Hedge Fund Activity: Q1 2015 in Review
42 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q1 2015, worth a combined $8.23M — down 48% from $15.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ATNM positions and 3 closed out — a net gain of 6 holders — while 17 added to existing stakes and 8 trimmed.
The largest buyer was Vanguard Group, adding an estimated $966K. The largest seller was Patten & Patten, exiting entirely with an estimated $359K sold.
- 42 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q1 2015, up from 36 in Q4 2014.
- Funds reported $8.23M of Actinium Pharmaceuticals stock for Q1 2015, down 48% quarter-over-quarter.
- 9 funds opened new Actinium Pharmaceuticals positions in Q1 2015 and 3 closed out, a net change of +6 holders.
- The largest Actinium Pharmaceuticals buyer in Q1 2015 was Vanguard Group, an estimated $966K added.
- The largest Actinium Pharmaceuticals seller in Q1 2015 was Patten & Patten, an estimated $359K sold.
Based on aggregated 13F filings for Q1 2015.